Pronalyse: Antibody Analysis Service Is Released to Boost Drug Discovery
Pronalyse is a new division of Creative Proteomics, which is an integrated CRO company with rich experience in providing drug development service for over 10 years. With years of experience in offering professional and high-quality products for academic use and pharmaceutical industries, Creative Proteomics Pronalyse division is able to offer remarkable antibody analysis service for researchers
At the current stage, Pronalyse focuses on providing protein-oriented analysis services to support manufacturers and researchers in the development of biopharmaceuticals, including antibodies, PEGylated proteins, peptide and protein drugs, vaccines, amino acids and their derivatives. The company's services include in vitro characterization, purity analysis, protein structure modification, in vivo safety inspections and pharmacokinetic analysis. "In the near future, we will expand our services to other biological drugs, such as vitamins, enzymes, nucleic acids and their derivatives, blood products, etc." said the marketing director of Creative Proteomics.
Antibodies are an important part of the human immune system. Since the US FDA first approved the use of antibodies in therapeutic drugs in the 1980s, antibody products, especially monoclonal antibodies (mAb), have become one of the main drivers of the growing biopharmaceutical market. There are many monoclonal antibody drugs that can be used to treat various types of diseases, and hundreds of therapeutic antibodies are undergoing clinical trials, and most of them are related to immunology and oncology.
The industrialization of monoclonal antibody production and analysis has been well adapted to the rapid growth in demand for monoclonal antibody production. However, the large molecular weight and complex heterotetrameric structure of antibody drugs may hinder the therapeutic efficacy of these antibody drugs. In order to solve these problems and improve the overall treatment efficiency, the detection, characterization and quantification of impurities, as well as important parameters related to the structural variants and modifications of the final product, affinity, stability, immunogenicity and safety are essential. In this reality, people need innovative and efficient analytical solutions and services.
“Creative Proteomics provides comprehensive antibody-related analysis services that meet the requirements of FDA and ICH guidelines. At the same time, it also provides a series of tailor-made solutions to design actual strategic plans related to customer projects and fully understand the characteristics of antibodies of interest.” said senior scientist of Creative Proteomics.
If you feel interested and want to learn more, please visit https://www.creative-proteomics.com/pronalyse/
About Pronalyse division of Creative Proteomics
Pronalyse is supported by specialists who are professional and skilled in protein chemistry, NMR, HPLC, mass spectrometry and bioinformatics. Currently, Pronalyse is dedicated to providing protein-oriented analysis service to support manufacturers and researchers in biopharmaceutical development, mainly including antibodies, PEGylated proteins, peptide and protein drugs, vaccines, amino acids and their derivatives. The service provided contains in vitro characterization, purity analysis, protein structure modification, in vivo safety check, and pharmacokinetics analysis, etc.